HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of soluble and cell-bound alpha 2,6 sialyltransferase in human colonic carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation.

Abstract
alpha 2,6 sialyltransferase towards the N-acetyllactosaminyl sequence (alpha 2,6 ST, E.C. 2.4.99.1) is one of the major sialyltransferases in human colonic cells; it strongly increases in human colorectal tumors and is largely expressed in fetal and neonatal rat colon. In this study we demonstrate that human colon carcinoma CaCo-2 cells, which differentiate spontaneously into enterocytes when maintained confluent for several days, exhibit a very high expression of alpha 2,6 ST both in the cell-bound and soluble form. When the CaCo-2 cells were cultured on porous membranes the soluble alpha 2,6 ST was mainly detected in the medium collected from the chamber corresponding to the basolateral face of the monolayer. The soluble alpha 2,6 ST could be concentrated and purified from the alpha 2,3 sialyltransferase by affinity chromatography on Blue Sepharose.
AuthorsF Dall'Olio, N Malagolini, F Serafini-Cessi
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 184 Issue 3 Pg. 1405-10 (May 15 1992) ISSN: 0006-291X [Print] United States
PMID1590800 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media
  • Sialyltransferases
  • beta-D-Galactoside alpha 2-6-Sialyltransferase
Topics
  • Carbohydrate Sequence
  • Cell Differentiation
  • Cell Line
  • Cell Membrane (enzymology)
  • Chromatography, Affinity
  • Colonic Neoplasms
  • Culture Media
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Sialyltransferases (isolation & purification, metabolism)
  • Time Factors
  • beta-D-Galactoside alpha 2-6-Sialyltransferase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: